Disorders of Oral Pigmentation

Updated: June 6, 2025

Mail Whatsapp PDF Image

Background

Oral pigmentation commonly affects various parts of the oral cavity.

Causes vary from iatrogenic factors like dental amalgam to complex disorders including Peutz-Jeghers syndrome and Addison disease.

Oral pigmented lesions arise from exogenous materials or excessive melanin.

Pigmented entities can originate from intrinsic or extrinsic sources. Color varies based on pigment source, quantity, and depth.

Melanin is brown but gives eyes colors like blue, gray, brown, or black due to light absorption and reflection properties explained by Tyndall effect.

Clinicians should inspect oral cavities and perform biopsies on undiagnosed pigmented lesions.

Patients with oral melanoma often remember previous pigmentation in the same area months to years before diagnosis.

Epidemiology

Oral pigmentation prevalence was 93.2% in black, 12.5% in white, 70% in native children.

A study of 1,300 Israeli Jewish schoolchildren showed 13.5% had physiological pigmentation in Middle Eastern children.

Diffuse pigmentations appear in about 92% of Addison patients. Amalgam tattoos are the most common oral pigmented lesions biopsied for histopathological examination.

Melanotic macule is a common pigmented oral mucosa lesion after amalgam tattoo. The average age at diagnosis of PJS is 23 years in men and 26 years in women.

Oral nevi occur in younger individuals, whereas malignant melanoma primarily affects those over 40 and is rare under 20.

Anatomy

Pathophysiology

Physiologic pigmentation is higher melanin production by melanocytes in individuals with darker skin.

Pigmentation arises from increased melanocytic activity but not more melanocytes. Flat and symmetrical lesions appear as even light-to-dark brown pigmentation.

It does not change normal tissue structure but can show as pinpoint pigmentation on the fungiform papillae of the tongue.

Pigmented macules vary in size and brown shades, appearing periorally, on lips, and buccal mucosae.

Addison disease results from adrenal cortex destruction to cause insufficient hormone production and increased ACTH levels.

Etiology

The causes of oral pigmentation are:

Physiological pigmentation

Systemic diseases

Oral mucosal insults

Developmental and neoplastic processes

Inflammatory causes

Pathologic Causes

Genetics

Prognostic Factors

Around 48% of PJS patients develop cancer by age 57, with intestinal polyps being the main morbidity cause.

The mean cancer diagnosis age is 42.9 years, with a 93% risk for PJS-related cancers in ages 15-64.

Amalgam tattoos have an excellent prognosis with no associated morbidity or sequelae in patients.

Oral nevi are benign, except junctional nevi that may lead to melanoma, which is frequently misdiagnosed until it becomes advanced and severe.

The oral mucosa’s lamina propria lacks distinct dermal layers that makes Clark levels unsuitable for describing mucosal melanomas due to architectural differences.

Mucosal melanoma staging relies on insights from more common cutaneous melanoma experiences.

Clinical History

Collect details including the chief complaint, history of present illness, medical and family history to understand clinical history of patients.

Physical Examination

Extraoral Examination

Intraoral Examination

Regional Lymph Node Examination

Systemic Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Acute symptoms are:

Post-inflammatory hyperpigmentation, drug-induced pigmentation, acute Addisonian crisis

Chronic symptoms are:

Racial pigmentation, Peutz-Jeghers syndrome, Laugier-Hunziker syndrome

Differential Diagnoses

McCune-Albright Syndrome

Melanocytic macule

Oral Melanoacanthoma

Peutz-Jeghers Syndrome

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

In amalgam tattoos cases, there are no medication or treatment is necessary.

Oral melanoma rarely benefits from medical therapy or chemotherapeutic medications to reduce tumor volume.

Drug therapy, radiation, and immunotherapy treat cutaneous melanoma but may not benefit oral melanoma patients.

Dacarbazine is ineffective for oral melanoma, but combined with interleukin 2 may help.

Success reported with interferon alfa and radiation therapy.

Cancer centers use surgical excision and interleukin 2 to prevent recurrence.

Rarity of lesions complicates assembling cohort study groups for therapeutic evaluation.

Investigating interferon and immunotherapies prompts future research on multimodal therapy incorporation.

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

use-of-non-pharmacological-approach-for-disorders-of-oral-pigmentation

Patient should quit smoking for longer period. Increase balanced diet with adequate vitamins and minerals.

Arrange screening for malnutrition in at-risk populations in daily intervals.

Use lip balm with proper SPF level and increase the sun protection.

Proper awareness about disorders of oral pigmentation should be provided and its related causes with management strategies.

Appointments with dentist and preventing recurrence of disorder is an ongoing life-long effort.

Medications are prescribed toward the GI aspects of the disease.

There are no medications that are directed specifically for treatment of oral lesions.

use-of-intervention-with-a-procedure-in-treating-disorders-of-oral-pigmentation

Push enteroscopy and intraoperative enteroscopy with polypectomy can effectively reduce repeated small bowel resections.

Laparotomy and resection are indicated for recurrent intussusception, obstruction, or intestinal bleeding.

Excisional surgery with clear margins is preferred for early local recurrence.

Lymphoscintigraphy and blue-dye biopsy do not predict melanoma drainage.

Surgical lymph node harvesting requires identifying positive nodes as prophylactic neck dissection is not recommended for oral melanoma.

use-of-phases-in-managing-disorders-of-oral-pigmentation

In the diagnostic confirmation phase, the goal is to confirm if pigmentation is benign, reactive, or malignant.

In supportive care and management phase, patients should receive required attention such as lifestyle modification and interventional procedures.

The regular follow-up visits with the dentist are scheduled to check the improvement of patients along with treatment response.

Medication

Media Gallary

Content loading

Latest Posts

Disorders of Oral Pigmentation

Updated : June 6, 2025

Mail Whatsapp PDF Image



Oral pigmentation commonly affects various parts of the oral cavity.

Causes vary from iatrogenic factors like dental amalgam to complex disorders including Peutz-Jeghers syndrome and Addison disease.

Oral pigmented lesions arise from exogenous materials or excessive melanin.

Pigmented entities can originate from intrinsic or extrinsic sources. Color varies based on pigment source, quantity, and depth.

Melanin is brown but gives eyes colors like blue, gray, brown, or black due to light absorption and reflection properties explained by Tyndall effect.

Clinicians should inspect oral cavities and perform biopsies on undiagnosed pigmented lesions.

Patients with oral melanoma often remember previous pigmentation in the same area months to years before diagnosis.

Oral pigmentation prevalence was 93.2% in black, 12.5% in white, 70% in native children.

A study of 1,300 Israeli Jewish schoolchildren showed 13.5% had physiological pigmentation in Middle Eastern children.

Diffuse pigmentations appear in about 92% of Addison patients. Amalgam tattoos are the most common oral pigmented lesions biopsied for histopathological examination.

Melanotic macule is a common pigmented oral mucosa lesion after amalgam tattoo. The average age at diagnosis of PJS is 23 years in men and 26 years in women.

Oral nevi occur in younger individuals, whereas malignant melanoma primarily affects those over 40 and is rare under 20.

Physiologic pigmentation is higher melanin production by melanocytes in individuals with darker skin.

Pigmentation arises from increased melanocytic activity but not more melanocytes. Flat and symmetrical lesions appear as even light-to-dark brown pigmentation.

It does not change normal tissue structure but can show as pinpoint pigmentation on the fungiform papillae of the tongue.

Pigmented macules vary in size and brown shades, appearing periorally, on lips, and buccal mucosae.

Addison disease results from adrenal cortex destruction to cause insufficient hormone production and increased ACTH levels.

The causes of oral pigmentation are:

Physiological pigmentation

Systemic diseases

Oral mucosal insults

Developmental and neoplastic processes

Inflammatory causes

Pathologic Causes

Around 48% of PJS patients develop cancer by age 57, with intestinal polyps being the main morbidity cause.

The mean cancer diagnosis age is 42.9 years, with a 93% risk for PJS-related cancers in ages 15-64.

Amalgam tattoos have an excellent prognosis with no associated morbidity or sequelae in patients.

Oral nevi are benign, except junctional nevi that may lead to melanoma, which is frequently misdiagnosed until it becomes advanced and severe.

The oral mucosa’s lamina propria lacks distinct dermal layers that makes Clark levels unsuitable for describing mucosal melanomas due to architectural differences.

Mucosal melanoma staging relies on insights from more common cutaneous melanoma experiences.

Collect details including the chief complaint, history of present illness, medical and family history to understand clinical history of patients.

Extraoral Examination

Intraoral Examination

Regional Lymph Node Examination

Systemic Examination

Acute symptoms are:

Post-inflammatory hyperpigmentation, drug-induced pigmentation, acute Addisonian crisis

Chronic symptoms are:

Racial pigmentation, Peutz-Jeghers syndrome, Laugier-Hunziker syndrome

McCune-Albright Syndrome

Melanocytic macule

Oral Melanoacanthoma

Peutz-Jeghers Syndrome

In amalgam tattoos cases, there are no medication or treatment is necessary.

Oral melanoma rarely benefits from medical therapy or chemotherapeutic medications to reduce tumor volume.

Drug therapy, radiation, and immunotherapy treat cutaneous melanoma but may not benefit oral melanoma patients.

Dacarbazine is ineffective for oral melanoma, but combined with interleukin 2 may help.

Success reported with interferon alfa and radiation therapy.

Cancer centers use surgical excision and interleukin 2 to prevent recurrence.

Rarity of lesions complicates assembling cohort study groups for therapeutic evaluation.

Investigating interferon and immunotherapies prompts future research on multimodal therapy incorporation.

Other Clinical

Patient should quit smoking for longer period. Increase balanced diet with adequate vitamins and minerals.

Arrange screening for malnutrition in at-risk populations in daily intervals.

Use lip balm with proper SPF level and increase the sun protection.

Proper awareness about disorders of oral pigmentation should be provided and its related causes with management strategies.

Appointments with dentist and preventing recurrence of disorder is an ongoing life-long effort.

Other Clinical

Push enteroscopy and intraoperative enteroscopy with polypectomy can effectively reduce repeated small bowel resections.

Laparotomy and resection are indicated for recurrent intussusception, obstruction, or intestinal bleeding.

Excisional surgery with clear margins is preferred for early local recurrence.

Lymphoscintigraphy and blue-dye biopsy do not predict melanoma drainage.

Surgical lymph node harvesting requires identifying positive nodes as prophylactic neck dissection is not recommended for oral melanoma.

In the diagnostic confirmation phase, the goal is to confirm if pigmentation is benign, reactive, or malignant.

In supportive care and management phase, patients should receive required attention such as lifestyle modification and interventional procedures.

The regular follow-up visits with the dentist are scheduled to check the improvement of patients along with treatment response.

Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
 
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses